As a continuation of this work, we showed that CXCR6 was preferentially expressed by CD8+ TRM after intranasal vaccination in mice with a vector targeting DC (70) and also on intratumoral CD8+ TRM derived from human lung cancer (12). The gene discussed is CXCR6; the disease is lung carcinoma.